Moreover, the analysis of IHC staining implied that the chemotherapy resistance CRC patients had a higher expression of ATP7A protein than the chemotherapy response patients and the metastatic CRC patients (TNM Stage IV) had a higher expression of ATP7A in tumor tissue than locally advanced CRC patients (Figure 1B). The gene discussed is ATP7A; the disease is colorectal carcinoma.